Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advisory Committees Free Of Conflicts May Be Unfeasible, FDA Review Says

This article was originally published in The Tan Sheet

Executive Summary

FDA's policy of granting waivers for financial conflicts of interest for advisory committee members is supported by an independent review commissioned by the agency, which determined that constructing advisory committees free from conflicts of interest would be expensive and time-consuming and may be unfeasible for certain topics and fields of expertise
Advertisement

Related Content

Advisory Committee Policy Allows Members With Financial Conflicts To Vote
Advisory Committee Policy Allows Members With Financial Conflicts To Vote
Advisory Committee Policy Allows Members With Financial Conflicts To Vote
FDA advisory committee changes
Draft Conflict Of Interest Policy Affects Status Of Many FDA Cmte. Members

Topics

Advertisement
UsernamePublicRestriction

Register

PS101168

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel